Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice (Q45876434)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2004

Language	Label	Description	Also known as
English	Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice	scientific article published in July 2004

Statements

scholarly article

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice (English)

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

0 references

Coagulation factor VIII

0 references

0 references

7

object named as

Hans D Ochs

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

author name string

Peiqing Ye

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

Arthur R Thompson

2

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

Rita Sarkar

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

Zhenping Shen

4

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

David P Lillicrap

5

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

Randal J Kaufman

6

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

David J Rawlings

8

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

Carol H Miao

9

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

publication date

1 July 2004

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

Molecular Therapy

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

10

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

117-126

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Structure and function of the factor VIII gene and protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Antibodies with hydrolytic activity towards factor VIII in patients with hemophilia A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Partial correction of murine hemophilia A with neo-antigenic murine factor VIII.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

High-Level Factor VIII Gene ExpressionIn VivoAchieved by Nonviral Liver-Specific Gene Therapy Vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

The canine factor VIII 3'-untranslated region and a concatemeric hepatocyte nuclear factor 1 regulatory element enhance factor VIII transgene expression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Complete and sustained phenotypic correction of hemophilia B in mice following hepatic gene transfer of a high-expressing human factor IX plasmid

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Gene therapy for the hemophilias

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Cross-presentation: a general mechanism for CTL immunity and tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.04.009

7 January 2021

Identifiers

10.1016/J.YMTHE.2004.04.009

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15233948

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45876434&oldid=2088262884"